Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema

Retina. 2006 Mar;26(3):356-7. doi: 10.1097/00006982-200603000-00018.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Female
  • Humans
  • Injections
  • Lens Implantation, Intraocular / adverse effects
  • Macular Edema / drug therapy*
  • Macular Edema / etiology
  • Male
  • Middle Aged
  • Phacoemulsification / adverse effects
  • Pseudophakia / drug therapy*
  • Pseudophakia / etiology
  • Vascular Endothelial Growth Factor A / immunology
  • Vitreous Body

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab